Results 191 to 200 of about 6,535 (217)
Some of the next articles are maybe not open access.

Analysis of some immunogenic properties of the recombinant Sporothrix schenckii Gp70 expressed in Escherichia coli.

Future Microbiology, 2019
AIM Sporothrix schenckii is the causative agent of sporotrichosis. A 70-kDa glycoprotein, Gp70, is a candidate for the development of prophylactic alternatives to control the disease, and its gene (GP70) is predicted to encode for a protein of 43 kDa ...
J. A. Martínez-Álvarez   +13 more
semanticscholar   +1 more source

Sporothrix schenckii

2012
Sporothrix schenckii has a worldwide distribution. The majority of cases of sporotrichosis occur in North America, South America, and Japan. Environmental niches include sphagnum moss, decaying vegetation, soil, and hay. It is a dimorphic fungus that grows as a mold at 37 ° C.
openaire   +1 more source

Potassium iodide and miltefosine inhibit biofilms of Sporothrix schenckii species complex in yeast and filamentous forms.

Medical Mycology, 2018
This study aimed to evaluate the yeast biofilm growth kinetics and ultrastructure of Sporothrix schenckii complex and assess their mature biofilm susceptibility in filamentous and yeast forms to potassium iodide (KI) and miltefosine (MIL). Yeast biofilms
R. Brilhante   +14 more
semanticscholar   +1 more source

Cutaneous Sporothrix schenckii of the Human Eyelid

Ophthalmic Plastic & Reconstructive Surgery, 2010
An 87-year-old patient presented with a 6-week history of an isolated progressive destructive nodular eyelid mass, secondary nodular and ulcerative lesions, and regional painful lymphadenopathy. After 4 weeks, fungal cultures demonstrated Sporothrix schenckii. S.
Jemshed A. Khan   +3 more
openaire   +3 more sources

Terpinen-4-ol inhibits the growth of Sporothrix schenckii complex and exhibits synergism with antifungal agents.

Future Microbiology, 2019
Aim: This study investigated the effect of terpinen-4-ol against Sporothrix schenckii complex and its interactions with antifungals. Materials & methods: The antifungal activity of terpinen-4-ol was evaluated by broth microdilution.
R. Brilhante   +10 more
semanticscholar   +1 more source

The nature of the secondary conidia of Sporothrix schenckii

Mycopathologia et Mycologia Applicata, 1970
Observations of secondary conidium production in an African strain ofS. schenckii revealed that secondary conidia are produced (1) acropetally on short sterigmata, (2) sympodially on short conidial appendages, and/or (3) sympodially or acropetally on short sporogenous cells which arise directly from the primary conidium. The secondary conidia therefore
openaire   +3 more sources

Sporothrix schenckii tenosynovitis: A case report

The Journal of Hand Surgery, 1986
Sporothrix schenckii is a fungus known to cause infection of skin in the subcutaneous tissues. In this case tenosynovitis was caused by sporotrichosis resulting in rupture of the extensor tendon. Excision of the involved tenosynovium and repair of the tendons were done.
Francis G. Middleton   +2 more
openaire   +3 more sources

Sporothrix schenckii — a freeze‐fracture study

Journal of Basic Microbiology, 1990
AbstractFreeze‐fracture electron microscopy of a pathogenic dimorphic fungus Sporothrix schenckii revealed planar views of cell structures corresponding to those described already on thin sections. In addition to the characteristic differences in cell wall thickness between conidia, yeast forms and filaments, variations in plasma membrane invaginations
Augustin Svoboda   +1 more
openaire   +3 more sources

Pentamidine inhibits the growth of Sporothrix schenckii complex and exhibits synergism with antifungal agents.

Future Microbiology, 2018
AIM The purpose of this study was to evaluate the effects of the antileishmanials meglumine antimoniate and pentamidine against Sporothrix schenckii complex.
R. Brilhante   +10 more
semanticscholar   +1 more source

Innate Immune Responses to Sporothrix schenckii: Recognition and Elimination

Mycopathologia, 2022
Peng Lin   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy